Dear Patients and Families –

Recently the FDA discovered that some ranitidine (Zantac) formulations contain a nitrosamine impurity called N-nitrosodimethylamine (NDMA) at low levels. NDMA is classified as a probable human carcinogen. NDMA is a known environmental contaminant and found in water and foods, including meats, dairy products, and vegetables. This carcinogen results in increased risk in the long-term – there is no known short term concern. The FDA is not calling for individuals to stop taking ranitidine at this time. However, patients taking prescription ranitidine who wish to discontinue use may seek alternative treatment options.

If you or your child is on zantac as prescribed by our office, or taken as an over-the-counter medication, we suggest that you contact your primary provider via MyChart message, call-in-hour, or in-person visit to discuss other options and alternatives. We will also be reaching out directly to our patients known to be on this medication.

The providers and staff at CMO